Achieve Life Sciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ACHV Nasdaq 2836 www.achievelifesciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Achieve Life Sciences, Inc.

ACHV: CEO Enlists New Commercialization Team - May 13th, 2026 2:30 am
Achieve Life Sciences Inc (ACHV) Q1 2026 Earnings Call Highlights: Strategic Financing and ... - May 12th, 2026 5:04 pm
Achieve Life Sciences, Inc. Q1 2026 Earnings Call Summary - May 12th, 2026 10:55 am
Achieve Life Sciences Q1 Earnings Call Highlights - May 12th, 2026 8:08 am
Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma - May 12th, 2026 5:05 am
Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates - May 12th, 2026 5:00 am
Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026 - May 5th, 2026 6:30 am
ACHV: Change of Command Brings Material Funding - Apr 28th, 2026 3:38 am
Achieve Life Sciences Launches Up to $354 Million Private Placement; Names Andrew Goldberg CEO; Shares Rise - Apr 16th, 2026 7:36 am
Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors - Apr 16th, 2026 6:57 am
Achieve Life Sciences Announces Up to $354 Million Private Placement - Apr 16th, 2026 6:53 am
Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions - Apr 15th, 2026 6:00 am
Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability - Mar 26th, 2026 6:30 am
Achieve Life Sciences, Inc. Q4 2025 Earnings Call Summary - Mar 25th, 2026 6:30 am
Achieve Life Sciences Inc (ACHV) Q4 2025 Earnings Call Highlights: Strategic Advances and ... - Mar 24th, 2026 1:02 pm
ACHV: 2025 Results - Mar 24th, 2026 11:36 am
Achieve Life Sciences Q4 Earnings Call Highlights - Mar 24th, 2026 8:51 am
Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - Mar 24th, 2026 5:00 am
Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026 - Mar 17th, 2026 6:30 am
Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study - Mar 4th, 2026 6:00 am